We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Gtx, Inc. | NASDAQ:GTXI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.20 | 1.18 | 1.20 | 0 | 00:00:00 |
From Jan 2020 to Jan 2025
GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, and other senior executive management team members will present a company overview at the Baird 2018 Global Healthcare Conference on Thursday, September 6, 2018 at 9:05 am ET in New York.
A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.
About GTx
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005108/en/
GTx, Inc.Investors:Argot PartnersKimberly Minarovich or Sam Martin212-600-1902orMedia:Red House ConsultingDenise Powell, 510-703-9491denise@redhousecomms.com
1 Year Gtx, Inc. Chart |
1 Month Gtx, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
